Obsidian Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:N/A
Industry:Biotech
Founded:2015
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Obsidian Therapeutics's estimated annual revenue is currently $8.2M per year.
  • Obsidian Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Obsidian Therapeutics has 53 Employees.
  • Obsidian Therapeutics grew their employee count by 51% last year.
  • Obsidian Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$8.7M56-12%N/A-N/A
#2
$8.7M5660%N/A-N/A
#3
$16.4M10614%N/A-N/A
#4
$89.4M577N/AN/A-N/A
#5
$116.9M754N/AN/A-N/A
#6
N/A220N/AN/A-N/A
#7
$15.3M99-17%N/A-N/A
#8
N/A94N/AN/A-N/A
#9
$54.6M352N/AN/A-N/A
#10
$17.2M1119%N/A-N/A
Missing a competitor? Contribute!?
Submit

Obsidian Therapeutics, founded in 2015, aspires to extend adoptive immunotherapy to every patient with cancer. We do this by building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients. We create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs. With this unique approach, we can dramatically improve on the current generation of cell therapies. Headquartered in Cambridge, MA, Obsidian has assembled an industry-leading team of experts in immunology, cell therapy, and oncology. We continue to build our team so please check our website (www.obsidiantx.com) often for job opportunities.

keywords:Healthcare,Human Resources Hr,Pharmaceuticals

53

Number of Employees

$8.2M

Revenue (est)

1

Current Jobs

51%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Obsidian Therapeutics News

09/07/2019 - Former Sigilion Exec Paul Wotton Named Obsidian ...

Obsidian Therapeutics has appointed Paul Wotton to serve as its new CEO. Wotton succeeds CEO Michael Gilman, who had been splitting his ...

09/08/2019 - Obsidian Therapeutics Announces Strengthening of Executive ...

CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Obsidian Therapeutics, a biotechnology company pioneering controllable cell and gene ...

01/18/2019 - Obsidian Therapeutics Announces Strategic Collaboration ...

Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$5.3M53N/AN/A-N/A
#2
$8.2M5320%N/A-N/A
#3
$8.2M5318%$39M-N/A
#4
N/A5326%N/A-N/A
#5
$13.5M530%N/A-N/A